{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:43:21Z","timestamp":1774467801639,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2,018YFC131,1505"],"award-info":[{"award-number":["2,018YFC131,1505"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.amjcard.2022.08.021","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T01:13:51Z","timestamp":1665969231000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy and Safety of Sustained-Release Metoprolol With Dronedarone After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation: A Propensity Matched Analysis"],"prefix":"10.1016","volume":"185","author":[{"given":"Pei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2022.08.021_bib0001","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjqcco\/qcaa061","article-title":"Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990\u20132017: results from the Global Burden of Disease Study 2017","volume":"7","author":"Dai","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0003","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10840-020-00741-x","article-title":"Significance of early recurrence of atrial fibrillation after catheter ablation: a nationwide Danish cohort study","volume":"60","author":"Hodges","year":"2021","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0004","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.1038\/s41598-018-28072-y","article-title":"The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set","volume":"8","author":"Mujovi\u0107","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0005","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.amjcard.2016.06.045","article-title":"Effect and significance of early reablation for the treatment of early recurrence of atrial fibrillation after catheter ablation","volume":"118","author":"Yanagisawa","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003909","article-title":"ADVICE Trial Investigators*. Redefining the blanking period After catheter ablation for paroxysmal atrial fibrillation: insights From the ADVICE (adenosine following pulmonary vein isolation to target dormant conduction elimination) trial","volume":"9","author":"Willems","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00399-021-00836-6","article-title":"Late arrhythmia recurrence after atrial fibrillation ablation: incidence, mechanisms and clinical implications","volume":"33","author":"Erhard","year":"2022","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0008","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0009","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1080\/03007995.2018.1479245","article-title":"Metoprolol in the treatment of cardiovascular disease: a critical reappraisal","volume":"34","author":"Grassi","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0010","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.amjcard.2022.08.021_bib0011","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5543\/tkda.2021.41347","article-title":"Effect of atrial fibrillation on quality of life (AFEQT) questionnaire: a Turkish validity and reliability study","volume":"49","author":"G\u00fcne\u015f","year":"2021","journal-title":"Turk Kardiyol Dern Ars"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0012","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0013","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/europace\/euu342","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial","volume":"17","author":"Walfridsson","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0015","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/pace.14060","article-title":"Early recurrence after pulmonary vein isolation is associated with inferior long-term outcomes: insights from a retrospective cohort study","volume":"43","author":"Kalinsek","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0016","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/jce.13190","article-title":"Recurrences in the blanking period and 12-month success rate by continuous cardiac monitoring after cryoablation of paroxysmal and non-paroxysmal atrial fibrillation","volume":"28","author":"Pieragnoli","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"10.1016\/j.amjcard.2022.08.021_bib0017","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jchf.2019.03.005","article-title":"Heart failure and atrial fibrillation, like fire and fury","volume":"7","author":"Carlisle","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0018","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0019","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1093\/eurheartj\/ehaa733","article-title":"Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation","volume":"41","author":"Clemente-Morag\u00f3n","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4330\/wjc.v8.i11.638","article-title":"Mechanisms and clinical significance of early recurrences of atrial arrhythmias after catheter ablation for atrial fibrillation","volume":"8","author":"Liang","year":"2016","journal-title":"World J Cardiol"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.yjmcc.2020.01.011","article-title":"Effects of sympatho-vagal interaction on ventricular electrophysiology and their modulation during beta-blockade","volume":"139","author":"Chin","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0022","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.4022\/jafib.1726","article-title":"Early recurrences during the blanking period after atrial fibrillation ablation","volume":"10","author":"Liang","year":"2018","journal-title":"J Atr Fibrillation"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0023","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1038\/s41598-018-31133-x","article-title":"Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation","volume":"8","author":"Kornej","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0024","first-page":"27","article-title":"Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation","volume":"5","author":"Schweizer","year":"2011","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.amjcard.2022.08.021_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2008.06.010","article-title":"Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study","volume":"156","author":"Davy","year":"2008","journal-title":"Am Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914922008980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914922008980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:07:07Z","timestamp":1762078027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914922008980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":25,"alternative-id":["S0002914922008980"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2022.08.021","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Sustained-Release Metoprolol With Dronedarone After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation: A Propensity Matched Analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2022.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}